• Ticker:- BBH;false;MVBBH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 09/15/14

    • 30-Day SEC Yield1

      -0.14%
    • Total Net Assets

      $524.1M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/19/2014
  • Portfolio Composition (%)
    as of 09/15/14

    • % of Net Assets
    • Stocks

      99.86
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.14
  • Download All HoldingsAll Holdings (%)as of 09/15/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    849,942
    85,835,64316.38
    Amgen Inc
    AMGN US
    462,115
    63,758,00712.17
    Celgene Corp
    CELG US
    580,111
    51,896,7309.90
    Biogen Idec Inc
    BIIB US
    146,726
    46,969,9278.96
    Vertex Pharmaceuticals Inc
    VRTX US
    289,925
    26,710,7905.10
    Regeneron Pharmaceuticals Inc
    REGN US
    69,230
    23,955,6574.57
    Alexion Pharmaceuticals Inc
    ALXN US
    142,507
    22,860,9734.36
    Illumina Inc
    ILMN US
    121,069
    20,351,6993.88
    Pharmacyclics Inc
    PCYC US
    154,207
    18,665,2153.56
    Qiagen Nv
    QGEN US
    768,260
    17,984,9673.43
    Biomarin Pharmaceutical Inc
    BMRN US
    264,328
    17,654,4673.37
    Medivation Inc
    MDVN US
    183,930
    17,155,1513.27
    Incyte Corp Ltd
    INCY US
    332,831
    15,852,7413.02
    United Therapeutics Corp
    UTHR US
    106,939
    13,527,7842.58
    Alkermes Plc
    ALKS US
    246,667
    10,774,4152.06
    Cubist Pharmaceuticals Inc
    CBST US
    160,014
    10,586,5262.02
    Covance Inc
    CVD US
    118,000
    10,053,6001.92
    Intercept Pharmaceuticals Inc
    ICPT US
    35,991
    9,660,3441.84
    Isis Pharmaceuticals Inc
    ISIS US
    212,975
    8,271,9491.58
    Charles River Laboratories Internationa
    CRL US
    121,306
    7,309,9001.39
    Nps Pharmaceuticals Inc
    NPSP US
    225,928
    6,164,4451.18
    Cepheid Inc
    CPHD US
    126,295
    5,448,3661.04
    Myriad Genetics Inc
    MYGN US
    125,109
    4,553,9680.87
    Seattle Genetics Inc
    SGEN US
    107,240
    4,377,5370.84
    Ariad Pharmaceuticals Inc
    ARIA US
    514,047
    2,986,6130.57
    Other/Cash
    726,0170.14
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.